HSPB1 and neoplasm: These authors demonstrated that short term silencing of HspB1 using siRNA or permanent silencing using lentivirus-RNAi technology enhanced proteasome activity, abrogated metastatic potential, induced the regression of established breast tumors by tumor-specific CD8+ T cells and stimulated long-lasting memory responses [36].